UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement ...

The first quarter of 2025 saw a wave of significant advancements in clinical research across oncology, neurology, dermatology, respiratory, and rare diseases.

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials. The good news is that ...

In many cases, we’ve simply layered new tools onto an outdated operating model. The structure beneath—the way clinical trials ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Karen Peterson was diagnosed with stage 1 triple-negative breast cancer that quickly returned as stage 4. Joining a clinical ...

Phase II trials articles from across Nature Portfolio Phase II trials are conducted to provide evidence of the effectiveness of a therapeutic intervention in patients and to determine the optimal ...

With artificial intelligence (AI) fast becoming an ubiquitous part of everyday life, its further application in clinical ...

Gain insights to de-risk and accelerate your trials. Explore with us the value of integrating precision medicine into your clinical trials — from patient selection to operational efficiency.

Randomized controlled trials articles from across Nature Portfolio Randomized controlled trials are clinical trials in which at least two interventions — the test treatment and a control ...

According to research from Deloitte, HR professionals spend up to 57 percent of their work week on administrative tasks. HRCI CHAT changes that, empowering HR professionals to regain valuable time and ...